Ultragenyx Pharmaceutical, Inc. (RARE)
24.70
+0.91
(+3.83%)
USD |
NASDAQ |
Feb 06, 16:00
24.68
-0.02
(-0.06%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Profit Margin (Quarterly) : -112.8% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 9.32% |
| Johnson & Johnson | 20.83% |
| CorMedix, Inc. | -- |
| Insmed, Inc. | -260.0% |
| Apellis Pharmaceuticals, Inc. | 47.04% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -307.8% |
| Return on Assets | -42.32% |
| Return on Invested Capital | -53.69% |
| Gross Profit Margin (Quarterly) | 77.12% |
| Operating Margin (Quarterly) | -106.9% |
| Return on Net Operating Assets | -90.48% |